VKTX Viking Therapeutics, Inc.
$24.89▲ +2.81%
Healthcare
Other
After hours
$24.89▲ +0.00%
Oct 27, 5:56 PM ET
Volume 3.30M
Avg Volume (10D) 4.86M
Key Metrics & Fundamentals
Market Cap
$3.17B
P/E Ratio
–
Div Yield
0.00%
52W Range
23.82 - 43.15
% vs 50 MA
-19.70%
% vs 200 MA
-23.39%
RSI-14
38.5
MACD Histogram
-0.1300
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$125.17M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$132.47M
COGS
–
Operating Exp
$132.60M
Operating Income
-$132.60M
EBIT
-$132.60M
Pretax Income
-$128.02M
Net Income
-$128.02M
EPS (Diluted)
-1.10
Price & Volume History
Loading chart…
Recent News
Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
Zacks · Oct 27, 2026 7:53 AM ET
Should You Buy Viking Therapeutics Stock Ahead of Q3 Results?
Zacks · Oct 26, 2026 9:02 AM ET
Can Corcept Therapeutics Stock Rally 40% After This Dip?
Trefis · Oct 26, 2026 3:11 AM ET
Why Viking Therapeutics’ Oral Obesity Strategy Will Be a Make-or-Break Focus on Oct. 28
24/7 Wall St. · Oct 25, 2026 11:40 AM ET
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
Zacks · Oct 23, 2026 4:45 PM ET
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks · Oct 22, 2026 4:50 PM ET
NVO vs. VKTX: Which Obesity Stock Could Deliver Bigger Gains?
Zacks · Oct 22, 2026 11:31 AM ET
Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026
PR Newswire · Oct 21, 2026 4:05 PM ET
How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Zacks · Oct 21, 2026 9:20 AM ET
The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics
Zacks · Oct 21, 2026 8:06 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See VKTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.